This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
B-RAF with PLX4032
From Proteopedia
(Difference between revisions)
| Line 4: | Line 4: | ||
| - | <applet load='3og7' size='800' color='white' frame='true' align='right' caption=' | + | <applet load='3og7' size='800' color='white' frame='true' align='right' caption='BRAF' /> |
| - | <scene name='B-RAF_with_PLX4032/Plx_4032_only/2>PLX 4032</scene><br> | + | <scene name='B-RAF_with_PLX4032/Plx_4032_only/2'>PLX 4032</scene><br> |
<scene name='B-RAF_with_PLX4032/Atp/2'>ATP</scene><br> | <scene name='B-RAF_with_PLX4032/Atp/2'>ATP</scene><br> | ||
<scene name='B-RAF_with_PLX4032/Wild-type_b-raf/2'>Wild-Type B-RAF</scene> <br> | <scene name='B-RAF_with_PLX4032/Wild-type_b-raf/2'>Wild-Type B-RAF</scene> <br> | ||
| Line 13: | Line 13: | ||
<scene name='B-RAF_with_PLX4032/Superposition3og71uwh/5'>Superposition close up</scene> <br> | <scene name='B-RAF_with_PLX4032/Superposition3og71uwh/5'>Superposition close up</scene> <br> | ||
<scene name='B-RAF_with_PLX4032/Superposition3og71uwh/2'>Superposition active site</scene> <br> | <scene name='B-RAF_with_PLX4032/Superposition3og71uwh/2'>Superposition active site</scene> <br> | ||
| - | <scene name='B-RAF_with_PLX4032/Confirmation_change_dfg-in/1'>Confirmation Change DFG-In</scene> <br> | ||
| - | <scene name='B-RAF_with_PLX4032/Confirmation_change_dfg-out/1'>Confirmation Change DFG-Out</scene> | ||
Revision as of 19:12, 7 October 2010
B-RAF with PLX4032
PLX4032 is a newly synthesized drug that is being used to treat malignant melanoma with a specific mutation. The mutation is B-RAF^(V600E). This drug is highly selective for this mutation and will not bind to wild type B-RAF.
|
